November 2013 FDA Recall Drug by Teva Pharmaceuticals Usa, Inc.
D-747-2014 - Failed Stability Specifications

This Class III drug recall was voluntarily initiated by Teva Pharmaceuticals Usa, Inc. on November 14, 2013 for the product Drug. The FDA reported the reason for recall as failed stability specifications. The product was distributed Nationwide and the recall is currently terminated.

Recall Number: D-747-2014

Reason for Recall
Failed Stability Specifications: this product is below specification for preservative content.
Initiated
11-14-2013
Reported
01-29-2014
Quantity
234,242 bottles

Recall Profile & Regulatory Data

Class III - is a situation in which use of, or exposure to, a violative product is not likely to cause adverse health consequences.
Teva Pharmaceuticals USA, Inc.
Fluconazole Oral Suspension, 10 mg/mL, 35 ml bottle, RX only, Mfd by Cipla, Ltd., Goa, India, Dist by Teva Pharmaceuticals USA, Inc., Sellersville, PA. NDC: 0093-5414-95.

Batch or Lot Expiration Information

Lot# Lot: (Exp); V10316 (11/13), V10317 (11/13), V10320 (11/13), V10321 (11/13), V20086 (2/14), V20087 (2/14), V20089 (2/14), V20093 (2/14), V20094 (2/14), V20086 (2/14), V20118 (3/14), V20119 (3/14), V20147 (3/14), V20148 (3/14), V20152 (4/14), V20154 (4/14), V20155 (4/14), V20180 (4/14), V20181 (4/14), V20182 (4/14), V20203 (5/14), V20204 (5/14), V20233 (5/14), V20234 (5/14), V20273 (6/14), V20274 (6/14), V20275 (6/14), V20293 (8/14), V20294 (8/14), V20321 (9/14), V20322 (9/14), V20323 (9/14), V20324 (9/14), V20325 (9/14), V20326 (9/14), V20327 (9/14), V20369 (10/14), V20370 (10/14), V20410 (11/14), V20411 (11/14), V20412 (11/14), V30009 (12/14), V30010 (12/14), V30011 (12/14), V30056 (01/15), V30120 (2/15), V30122 (2/15), V30123 (2/15), V30163 (3/15), V30164 (3/15), V30165 (3/15), V30190 (3/15), V30249 (5/15), V30250 (5/15).